Does the presence of NAFLD influence prescribing behaviour in Type 2 diabetes?

Documents similaires

• Disparities in the monitoring and complication screening of people with Type 2 diabetes
  par: Hinton, W, et autres
  Publié: (2017)
• Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)
  par: Shah, S, et autres
  Publié: (2018)
• Is diabetes really a risk factor for acute eye infection?
  par: Ansari, AS, et autres
  Publié: (2017)
• Ethnic disparities in medication persistence in Type 2 diabetes: non-whites have reduced persistence
  par: McGovern, AP, et autres
  Publié: (2016)
• Ethnic and socioeconomic disparities in type 2 diabetes care: A trend analysis
  par: Hinton, W, et autres
  Publié: (2017)